Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Organization
NIH
Type
NIH
Number
PAR-19-150
Brief Description

The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of Exploratory/Developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.